Lupin

In News

Lupin Spins Out Two Oncology Programs to Kaveri Therapeutics to Advance its Oncology Strategy - PR Newswire

PR Newswire - Jul 21, 2026

Indian generics maker Lupin seeds US spinout Kaveri with cash, clinical-phase cancer assets - fiercebiotech.com

fiercebiotech.com - Jul 21, 2026

Earnings call transcript: Lupin posts record Q1 2026 revenue but misses EPS - Investing.com

Investing.com - Aug 07, 2026

Lupin Ltd (BOM:500257) (Q1 2027) Earnings Call Highlights: Record Revenue and Strategic ... - Yahoo Finance UK

Yahoo Finance UK - Aug 07, 2026

Netflix Sets ‘Lupin’ S4 Release Date - The Hollywood Reporter

The Hollywood Reporter - Jun 08, 2026

Lupin Pharmaceuticals recalls 2.5M prednisolone eye drop bottles over contamination concerns - Top Class Actions

Top Class Actions - Jul 29, 2026

Lupin recalls more than 2.5M bottles of eye drops due to possible contamination - Fierce Pharma

Fierce Pharma - Jul 13, 2026

Netflix’s 3-Part Spy Thriller Is the Perfect Binge Before Michael B. Jordan’s ‘Thomas Crown Affair’ - Collider

Collider - Aug 06, 2026

Lupin Q1 FY2027 Results - Lupin | Press Release - lupin.com

lupin.com - Aug 06, 2026

Netflix Unveils ‘Lupin’ Part 4 2026 Premiere Date and Poster - Deadline

Deadline - Jun 08, 2026

After Crushing Q1 Estimates, What's Next For Lupin? Macquarie Makes Its Case - NDTV Profit

NDTV Profit - Aug 07, 2026

Otsuka Pharmaceutical Co. v. Lupin Ltd. (Fed. Cir. 2026) - JD Supra

JD Supra - Jun 19, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment